×
We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Fabino Enterprises Ltd | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd | 2.95 | -1.93 | NA | -7.86 | 0 | |
| Syngene International Limited | 9325.0 | 150.0 | 9171.0 | 0.37 | 24,557 | 48.4 |
| Emcure Pharmaceuticals Limited | 12833.57 | 1176.22 | 12606.04 | 6.21 | 24337 | 32.3 |
| Pfizer Limited | 6,841.90 | 1,890.20 | 6,423.40 | 0.00 | 22558 | 147.0 |
Syngene International Limited, with Security Code 539268, is a leading player in the Healthcare Research- Analytics & Technology industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 791.9 | 864.7 | 726.5 | 821.3 | 877.1 | 948.4 | 799.3 | 830.1 |
| Expenses | 592.4 | 565.4 | 578.3 | 612.7 | 626.3 | 638.4 | 631.2 | 652.6 |
| Operating Profit | 199.5 | 299.3 | 148.2 | 208.6 | 250.8 | 310.0 | 168.1 | 177.5 |
| OPM % | 25.19% | 34.61% | 20.4% | 25.4% | 28.59% | 32.69% | 21.03% | 21.38% |
| Other Income | 25.1 | 15.3 | 49.7 | 16.4 | 18.0 | 18.4 | 16.6 | 14.2 |
| Interest | 6.3 | 8.5 | 7.4 | 7.0 | 6.7 | 10.1 | 5.9 | 7.4 |
| Depreciation | 93.6 | 95.7 | 91.7 | 93.7 | 92.3 | 89.6 | 94.6 | 100.1 |
| Profit before tax | 128.4 | 210.4 | 66.8 | 124.3 | 169.8 | 228.7 | 84.2 | 84.2 |
| Tax % | -20% | -9.8% | -25.2% | 22.3% | 27.5% | -23.7% | 12.1% | 21.4% |
| Net Profit | 99.8 | 189.8 | 73.9 | 96.6 | 123.1 | 174.4 | 74.0 | 66.2 |
| EPS in Rs | 2.48 | 4.72 | 1.84 | 2.41 | 3.06 | 0 | 1.83 | 1.65 |
| Metrics | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Sep 2025 | Dec 2025 | Dec 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 789.7 | 891.0 | 943.7 | 1,018.0 | 910.6 | 917.1 | 917.1 | 917.1 |
| Expenses | 619.9 | 646.2 | 660.1 | 674.4 | 711.1 | 707.9 | 707.9 | 707.9 |
| Operating Profit | 169.8 | 244.8 | 283.6 | 343.6 | 199.5 | 209.2 | 209.2 | 209.2 |
| OPM % | 21.5% | 27.47% | 30.05% | 33.75% | 21.91% | 22.81% | 22.81% | 22.81% |
| Other Income | 50.1 | 16.5 | 18.3 | 18.9 | 15.4 | -55.2 | -55.2 | -55.2 |
| Interest | 11.7 | 13.1 | 12.4 | 15.9 | 13.2 | 11.9 | 11.9 | 11.9 |
| Depreciation | 106.9 | 110.9 | 108.7 | 106.1 | 116.5 | 113.7 | 113.7 | 113.7 |
| Profit before tax | 69.3 | 137.3 | 180.8 | 240.5 | 85.2 | 99.0 | 99.0 | 99.0 |
| Tax % | 25.3% | -22.7% | -27.5% | -23.8% | -21.2% | 47.2% | 47.2% | 47.2% |
| Net Profit | 75.7 | 106.1 | 131.1 | 183.3 | 67.1 | 15.0 | 15.0 | 15.0 |
| EPS in Rs | 1.88 | 2.64 | 3.26 | 0 | 0 | 0.37 | 0.37 | 0.37 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 11% |
| 3 Years: | 9% |
| TTM: | 5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 4% |
| 3 Years: | 2% |
| TTM: | -5% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 12% |
| 3 Years: | 5% |
| 1 Year: | -7% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 13% |
| 3 Years: | 12% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 6% |
| 3 Years: | 4% |
| TTM: | -9% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 12% |
| 3 Years: | 5% |
| 1 Year: | -7% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|